The program--known as the clunky "At the Customer, For the Customer"--taps the parent company's wealth of expertise in the vaunted Six Sigma defect-reduction method, just-in-time manufacturing and such management pursuits as succession planning.
"With enzyme replacement, it's a single defect, and you correct that error, " says Joon Yun , partner at money management firm Palo Alto Investors, which has owned BioMarin stock for several years.